| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/08/2001 | WO2000057180A3 Use of lna in mass spectrometry |
| 02/08/2001 | WO2000056916A3 Detection of mutations in genes by specific lna primers |
| 02/08/2001 | WO2000053758A3 Compositions and methods for the treatment of immune related diseases |
| 02/08/2001 | WO2000041524A3 Isothermal amplification of dna |
| 02/08/2001 | WO2000034525A8 Toxicity typing using embryoid bodies |
| 02/08/2001 | WO2000026409A8 Amplified array analysis method and system |
| 02/08/2001 | DE19937230A1 Chimäre Proteine Chimeric proteins |
| 02/08/2001 | DE19937219A1 Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Ionenaustauscherchromatographie A process for the purification of the blood clotting factor VII-activating protease, its pro-enzyme or a mixture of both proteins by ion-exchange chromatography |
| 02/08/2001 | DE19935772A1 Verfahren zur relativen Quantifizierung der Methylierung von Cytosin Basen in amplifizierten Nukleinsäurefragmenten Method for the relative quantification of methylation of cytosine bases in nucleic acid amplified fragments |
| 02/08/2001 | DE19935749A1 Verfahren zur Chrakterisierung von Nukleinsäurefragmenten Method for Chrakterisierung of nucleic acid fragments |
| 02/08/2001 | DE19935302A1 Konjugate und Verfahren zu deren Herstellung sowie deren Verwendung zum Transport von Molekülen über biologische Membranen Conjugates and methods for their preparation and their use for transporting molecules across biological membranes |
| 02/08/2001 | DE19933078A1 Verfahren und Kit zur Bestimmung von DNA-Doppel-/Einzelstrangbrüchen und Vorrichtung zum kontrollierten Filtrieren von insbesondere DNA-Moleküle und/oder andere Moleküle/Molekülkomplexe enthaltenden flüssigen Medien mit Well-Filterplatten A method and kit for the determination of DNA double / single-strand breaks and device for controlled filtration of containing particular DNA molecules and / or other molecules / molecule complex liquid media with well filter plates |
| 02/08/2001 | CA2756675A1 A method for the determination of allelic imbalance by nucleic acid amplification assays |
| 02/08/2001 | CA2756673A1 Digital amplification |
| 02/08/2001 | CA2697207A1 Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications |
| 02/08/2001 | CA2391351A1 Transcription-free selex |
| 02/08/2001 | CA2387655A1 Sentrin-specific human proteases senp1-3 |
| 02/08/2001 | CA2387642A1 Methodology for identifying plants and other organisms having traits differing from a normal population |
| 02/08/2001 | CA2381958A1 Method for amplification of nucleic acids |
| 02/08/2001 | CA2381568A1 Instruments, methods and reagents for surface plasmon resonance |
| 02/08/2001 | CA2381437A1 G-protein coupled receptor and dna sequences thereof |
| 02/08/2001 | CA2381004A1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) or its receptor c-met and to integrins |
| 02/08/2001 | CA2380837A1 High affinity tgf.beta. nucleic acid ligands and inhibitors |
| 02/08/2001 | CA2380836A1 Nuclease variant and their use in genotyping assays |
| 02/08/2001 | CA2380822A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | CA2380794A1 Methods and apparatus for template capture and normalization for submicroliter reaction |
| 02/08/2001 | CA2380631A1 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 02/08/2001 | CA2380545A1 Nucleic acid ligands to cd40ligand |
| 02/08/2001 | CA2380535A1 High affinity vascular endothelial growth factor (vegf) receptor nucleic acid ligands and inhibitors |
| 02/08/2001 | CA2380519A1 Method for screening molecules for the treatment of huntington disease |
| 02/08/2001 | CA2380489A1 Modulating binding site on potassium channels used for screening |
| 02/08/2001 | CA2380473A1 Tenascin-c nucleic acid ligands |
| 02/08/2001 | CA2380428A1 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (app) |
| 02/08/2001 | CA2380407A1 Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses |
| 02/08/2001 | CA2380323A1 Inducible screen for drug discovery |
| 02/08/2001 | CA2379969A1 Low volume chemical and biochemical reaction system |
| 02/08/2001 | CA2379963A1 Mammalian cytokines; related reagents |
| 02/08/2001 | CA2379953A1 Assay for d-serine transport antagonist and use for treating psychosis |
| 02/08/2001 | CA2379360A1 Human g-protein coupled receptor |
| 02/08/2001 | CA2379250A1 Method of designing drugs through reverse polymorphism of target genes |
| 02/08/2001 | CA2379163A1 Method for characterizing nucleic acid fragments |
| 02/08/2001 | CA2378929A1 Serine proteases |
| 02/08/2001 | CA2378928A1 Methods for analyzing protein binding events |
| 02/08/2001 | CA2378901A1 Method for detecting and classifying nucleic acid hybridization |
| 02/08/2001 | CA2378331A1 Calcium channel transport polynucleotides, polypeptides, and antibodies |
| 02/08/2001 | CA2378182A1 Compositions and methods for the treatment of tumors |
| 02/08/2001 | CA2377064A1 Purine metabolism genes in plants |
| 02/08/2001 | CA2376929A1 Digital amplification |
| 02/08/2001 | CA2376489A1 Microarrays and their manufacture |
| 02/08/2001 | CA2374743A1 Human chaperone proteins |
| 02/07/2001 | EP1074842A1 Catalytic anti-factor VIII allo-antibodies |
| 02/07/2001 | EP1074836A2 High throughput Hplc method for determining log P values |
| 02/07/2001 | EP1074832A1 Improved electrochemical-sensor design |
| 02/07/2001 | EP1074634A1 Method for the diagnosis or the prognosis of Alzheimer disease therapeutical composition for preventing or treating Alzheimer disease |
| 02/07/2001 | EP1074633A1 Nucleotides for cycle sequencing of gc-rich templates |
| 02/07/2001 | EP1074624A1 Attenuated chicken-pox virus oka strain gene 62 and method for identifying virus strain for attenuated live chicken-pox vaccine by using the gene |
| 02/07/2001 | EP1074623A1 ABC transporter |
| 02/07/2001 | EP1074619A2 Promoter for neuropeptide FF and use thereof for therapy and diagnostics |
| 02/07/2001 | EP1074618A2 Cadherin materials and methods |
| 02/07/2001 | EP1074616A1 Process for purification of the factor VII-activating protease, its proenzyme or a mixture of both proteins, by ion-exchange chromatography |
| 02/07/2001 | EP1074559A1 Peptide nucleic acids |
| 02/07/2001 | EP1073905A1 Methods of selecting internalizing antibodies |
| 02/07/2001 | EP1073904A2 High-density, miniaturized arrays and methods of manufacturing same |
| 02/07/2001 | EP1073901A2 Immobilized substrate, separation gels produced therewith and method for detecting enzymatic activity after electrophoretic protein separation |
| 02/07/2001 | EP1073898A1 Methods for disease diagnosis from stool samples |
| 02/07/2001 | EP1073895A1 Dextran-coated surface |
| 02/07/2001 | EP1073892A1 Automated molecular pathology apparatus having independent slide heaters |
| 02/07/2001 | EP1073771A1 New method for the selection of clones of an eypression library involving rearraying |
| 02/07/2001 | EP1073770A2 Novel method for the identification of clones conferring a desired biological property from an expression library |
| 02/07/2001 | EP1073769A1 Primer extension methods for detecting nucleic acids |
| 02/07/2001 | EP1073768A2 Method for screening antimycotic substances using essential genes from s. cerevisiae |
| 02/07/2001 | EP1073767A1 Methods, kits and compositions for detecting and quantitating target sequences |
| 02/07/2001 | EP1073766A1 Methods and compositions pertaining to pd-loops |
| 02/07/2001 | EP1073765A2 Gene screening methods and related assays |
| 02/07/2001 | EP1073764A1 Membrane-permeant phosphoinositides |
| 02/07/2001 | EP1073763A1 Methods for transducing fusion molecules |
| 02/07/2001 | EP1073750A1 Preparation of human papillomavirus e1 having helicase activity and method therefor |
| 02/07/2001 | EP1073749A2 Enhancing immune responses to genetic immunization by using a chemokine |
| 02/07/2001 | EP1073746A2 Bacterial yjeq polypeptide family |
| 02/07/2001 | EP1073742A2 Human nucleic acid sequences of bladder tumour tissue |
| 02/07/2001 | EP1073741A2 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 02/07/2001 | EP1073739A2 Cd40-interacting and traf-interacting proteins |
| 02/07/2001 | EP1073738A2 Human k+ ion channel and therapeutic applications thereof |
| 02/07/2001 | EP1073736A1 Delayed rectifier potassium channel subunit |
| 02/07/2001 | EP1073734A2 Tumor associated nucleic acids and uses therefor |
| 02/07/2001 | EP1073733A1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY |
| 02/07/2001 | EP1073727A2 Human nucleic acid sequences from ovarian tumour tissue |
| 02/07/2001 | EP1073723A2 Ste20-related protein kinases |
| 02/07/2001 | EP1073721A1 Efficient purification of adenovirus |
| 02/07/2001 | EP1073719A2 Process for obtaining stem cells |
| 02/07/2001 | EP1073717A1 Methods of screening for agonists and antagonists of the interaction between the human kiaa0001 receptor and ligands thereof |
| 02/07/2001 | EP1073710A2 Non-stochastic generation of genetic vaccines and enzymes |
| 02/07/2001 | EP1073682A1 Heparanase specific molecular probes and their use in research and medical applications |
| 02/07/2001 | EP1073681A1 Cloning of a novel 7tm receptor axor-2 |
| 02/07/2001 | EP1073677A1 STAPHYLOCOCCUS AUREUS pyrH POLYPEPTIDES AND POLYNUCLEOTIDES |
| 02/07/2001 | EP1073669A2 Gcp |
| 02/07/2001 | EP1073465A1 T cell inhibitory receptor compositions and uses thereof |
| 02/07/2001 | EP1073460A1 Nucleic acid encoding hyaluronan synthase and methods of use |
| 02/07/2001 | EP0889973B1 Chain-termination type nucleic acid sequencing method including 2'-deoxyuridine-5'-triphosphate |
| 02/07/2001 | EP0754240A4 Ligase/polymerase-mediated genetic bit analysis?tm of single nucleotide polymorphisms and its use in genetic analysis |